Literature DB >> 25902807

Pain in Sleepwalking: A Clinical Enigma.

Régis Lopez1,2, Isabelle Jaussent2, Yves Dauvilliers1,2.   

Abstract

STUDY
OBJECTIVES: Sleepwalking is a disorder characterized by arousal specifically from slow wave sleep with dissociated brain activity that may be related to lower nociceptive state. Our objectives were to assess the frequency of chronic pain, headache, and migraine in sleepwalkers compared to controls, examine the impact and determinants of pain in sleepwalkers, and report analgesia frequency during injurious parasomnia episodes.
DESIGN: Cross-sectional case-control study.
SETTING: Data were collected at the Sleep Disorders Center, Montpellier, France. PARTICIPANTS: One hundred patients with sleepwalking were assessed for disease characteristics, sleep (polysomnography, sleepiness, and insomnia), pain (chronic pain, multidimensional pain inventory, headache, and migraine), depressive symptoms, and quality of life compared to 100 adult controls. Pain perception was retrospectively assessed during injurious parasomnia episodes. MEASUREMENTS AND
RESULTS: Raw association data showed that lifetime headache, migraine, and chronic pain at time of study were significantly associated with sleepwalking (also called somnambulism). Compared to controls, sleepwalkers reported more frequent daytime sleepiness, and depressive and insomnia symptoms. After adjustments, sleepwalking was associated with increased risk for headache and migraine only. Compared to pain-free sleepwalkers, sleepwalkers with chronic pain were more likely to be older and to have greater daytime sleepiness, insomnia, and depressive symptoms, with no difference in polysomnography assessment. Of the 47 sleepwalkers with at least one previous violent parasomnia episode, 78.7% perceived no pain during episodes, allowing them to remain asleep despite injury.
CONCLUSION: Our results highlight the clinical enigma of pain in sleepwalking patients with complaints of frequent chronic pain, migraine, and headache during wakefulness but who report retrospectively experience of analgesia during severe parasomnia episodes, suggesting a relationship between dissociated brain activity and nociceptive dysregulation.
© 2015 Associated Professional Sleep Societies, LLC.

Entities:  

Keywords:  analgesia; headache; pain; parasomnia; sleepwalking

Mesh:

Year:  2015        PMID: 25902807      PMCID: PMC4813363          DOI: 10.5665/sleep.5144

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  42 in total

1.  Sleep arousal response to experimental thermal stimulation during sleep in human subjects free of pain and sleep problems.

Authors:  G Lavigne; M Zucconi; C Castronovo; C Manzini; P Marchettini; S Smirne
Journal:  Pain       Date:  2000-02       Impact factor: 6.961

2.  Validation of the Insomnia Severity Index as an outcome measure for insomnia research.

Authors:  C H. Bastien; A Vallières; C M. Morin
Journal:  Sleep Med       Date:  2001-07       Impact factor: 3.492

3.  Identification of sleep-promoting neurons in vitro.

Authors:  T Gallopin; P Fort; E Eggermann; B Cauli; P H Luppi; J Rossier; E Audinat; M Mühlethaler; M Serafin
Journal:  Nature       Date:  2000-04-27       Impact factor: 49.962

4.  Daytime somnolence in adult sleepwalkers.

Authors:  Alex Desautels; Antonio Zadra; Marc-Antoine Labelle; Yves Dauvilliers; Dominique Petit; Jacques Montplaisir
Journal:  Sleep Med       Date:  2013-08-29       Impact factor: 3.492

5.  Objective daytime sleepiness in patients with somnambulism or sleep terrors.

Authors:  Régis Lopez; Isabelle Jaussent; Yves Dauvilliers
Journal:  Neurology       Date:  2014-10-29       Impact factor: 9.910

6.  Psychopathologic correlates of adult sleepwalking.

Authors:  Marc-Antoine Labelle; Alex Desautels; Jacques Montplaisir; Antonio Zadra
Journal:  Sleep Med       Date:  2013-10-08       Impact factor: 3.492

7.  Sleep and pain.

Authors:  Harvey Moldofsky
Journal:  Sleep Med Rev       Date:  2001-10       Impact factor: 11.609

8.  Functional impairment in adult sleepwalkers: a case-control study.

Authors:  Regis Lopez; Isabelle Jaussent; Sabine Scholz; Sophie Bayard; Jacques Montplaisir; Yves Dauvilliers
Journal:  Sleep       Date:  2013-03-01       Impact factor: 5.849

9.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

10.  GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls.

Authors:  S Akbarian; M M Huntsman; J J Kim; A Tafazzoli; S G Potkin; W E Bunney; E G Jones
Journal:  Cereb Cortex       Date:  1995 Nov-Dec       Impact factor: 5.357

View more
  6 in total

1.  Darwin's Predisposition and the Restlessness that Drives Sleepwalking.

Authors:  Michael Howell
Journal:  Sleep       Date:  2015-11-01       Impact factor: 5.849

2.  Is Restless Legs Syndrome Involved in Ambulation Related to Sleepwalking?

Authors:  Régis Lopez; Yves Dauvilliers
Journal:  Sleep       Date:  2016-04-01       Impact factor: 5.849

3.  Cryptic Restlessness and Sleepwalking.

Authors:  Michael Howell
Journal:  Sleep       Date:  2016-07-01       Impact factor: 5.849

4.  Altered brain perfusion patterns in wakefulness and slow-wave sleep in sleepwalkers.

Authors:  Marie-Ève Desjardins; Andrée-Ann Baril; Jean-Paul Soucy; Thien Thanh Dang-Vu; Alex Desautels; Dominique Petit; Jacques Montplaisir; Antonio Zadra
Journal:  Sleep       Date:  2018-05-01       Impact factor: 5.849

5.  Scalp and Source Power Topography in Sleepwalking and Sleep Terrors: A High-Density EEG Study.

Authors:  Anna Castelnovo; Brady A Riedner; Richard F Smith; Giulio Tononi; Melanie Boly; Ruth M Benca
Journal:  Sleep       Date:  2016-10-01       Impact factor: 5.849

6.  Migraine and sleep disorders: a systematic review.

Authors:  Cindy Tiseo; Alessandro Vacca; Anton Felbush; Tamara Filimonova; Annalisa Gai; Tatyana Glazyrina; Irina Anna Hubalek; Yelena Marchenko; Lucas Hendrik Overeem; Serena Piroso; Alexander Tkachev; Paolo Martelletti; Simona Sacco
Journal:  J Headache Pain       Date:  2020-10-27       Impact factor: 7.277

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.